all report title image

MIDDLE EAST AND ASIA INJECTABLE DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Middle East and Asia Injectable Drugs Market, by Product Type (Pre-filled Syringes, Auto-injectors, Pre-filled Pens, Pre-mixed IV Bags, and Others), by Drug Class (Anesthesia, Antibiotics, Antidotes, Antiemetic, Anti-infective, Anti-thrombolytic, Muscle Relaxant, Non Opioids, Opioids, Sedatives, and Others), by Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others (Epidural and Intrathecal)), and by End Users (Hospitals, Clinics, and Ambulatory Surgery Centers) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • Published In: 31 Aug, 2023
  • Code: CMI4891
  • Page number: 90
  • Formats:   Excel and PDF
  • Industry: Medical Devices

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By End Users
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Product approval and launches
    • Merges and Acquisitions
    • Key development
    • Middle East and Asia drug approval process
    • Regulatory Scenario
    • Reimbursement Scenario
    • Brand Analysis
    • PEST Analysis
    • Pricing Analysis
    • Technology Advancement
  4. Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic

    • Economic Impact
    • Impact on Clinical Trials and Drug Development
    • Government Initiatives
  5. Middle East and Asia Injectable Drugs Market, By Product Type, 2017 – 2028, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Pre-filled Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Vaccines
        • Blood Stimulants
        • Biologics
        • Others
    • Auto-injectors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Pre-filled Pens
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Pre-mixed IV Bags
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Sedative Products (Sedation)
        • Anesthesia Products (Anesthesia)
        • Pain Management Products (Post-operative analgesic pain management)
        • Chemotherapy Products (Chemotherapy)
        • Antibacterial Products (Infectious diseases)
        • Electrolyte and Nutrition Products (Electrolyte and Nutrition)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  6. Middle East and Asia Injectable Drugs Market, By Route of Administration, 2017 – 2028, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Intravenous (IV)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Intramuscular (IM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Subcutaneous (SC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others (Epidural and Intrathecal)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  7. Middle East and Asia Injectable Drugs Market, By Drug Class , 2017 – 2028, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Anesthesia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Antidotes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Antiemetic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Anti-thrombolytic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Muscle Relaxant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Non Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Sedatives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  8. Middle East and Asia Injectable Drugs Market, By End Users, 2017 – 2028, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  9. Middle East and Asia Injectable Drugs Market, By Country, 2017 – 2028, (US$ Mn)

    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2028
      • Country Trends
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2017 – 2028, (US$ Mn)
    • Asia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2017 – 2028, (US$ Mn)
  10. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
      • Kalbe Farma
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Pfizer Inc.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Novo Nordisk A/S
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Takeda Pharmaceutical Co. Ltd.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Livzon Pharmaceutical Group, Inc.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Sun Pharmaceutical Industries, Ltd.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Sanofi
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Novartis
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Tabuk
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      •  GlaxoSmithKline plc
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • AstraZeneca
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Gerresheimer AG
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
  11. Section

    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 30 market data tables and 35 figures on "

Middle East and Asia Injectable Drugs Market

” - forecast to 2028

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.